Table 2.
Sample characteristics.
| Participants n = 616 (258 women) | |
|---|---|
| Age [y] | 69 ± 5 (60–79) |
| Waist-to-hip ratio | 0.96 ± 0.085 (0.73–1.14) |
| BMI [kg/m2] | 27.5 ± 4 (17–41) |
| Smoking [%] (current/previous/never) | 7.5/33.1/59.4 |
| Mean Systolic BP [mmHg] | 136 ± 17 (89–197) |
| HbA1c [mmol/mol] (n = 611) | 5.4 [5.16–5.68] (3.84–12.38) |
| HDL [mU/mL] (n = 615) | 1.6 [1.32–1.92] (0.45–4.17) |
| Total cholesterol [mmol/L] | 5.9 ± 1.1 (2.3–10.8) |
| Physical activity [MET-minutes/week] (n = 516) | 4159 [2374.5–6919.5] (33.0−16398.0) |
| APOE status [% e4-carrier] (n = 584) | 20.9 |
| Depression scale (CES-D) [score] | 9.4 ± 5.1 (0–34) |
| Arterial hypertension [%] (yes) | 55.7 |
| Diabetes status [%] (none / type 1-medicated, type 2-medicated, type 2-non-medicated) | 84.4/0.5/12.3/2.8 |
| Current estrogen supplement [% females] (yes) | 7.3 |
| Cardiovascular diseases [%] (any) | 19.2 |
| Education [%] (without SS-LD/SS-LD/advanced SS-LD / advanced technical SS-LD / technical college ED / university ED) | 0/10.7/6.3/42.7/5.2/35.1 |
| White matter hyperintensities [%] (Fazekas score 0/1/2/3) | 23.5/59.8/16.2/0.5 |
Note: Data are mean ± SD (minimum-maximum) or median [Interquartile range] (minimum-maximum), unless indicated otherwise.
BMI: body mass index; BP: Blood pressure; MET: multiples of the resting metabolic rate; HbA1c: glycated hemoglobin A1c; HDL: high-density lipoproteins; APOE: Apolipoprotein E; CES-D: center for epidemiologic studies depression scale; SS-LD: secondary school-leaving degree; ED: entrance degree.